Royalty Pharma plc SEC filings RPRX
Royalty Pharma plc has 635 filings in SEC EDGAR's recent list, going back to Feb 13, 2020. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 4 | Insider transaction | Oct 5, 2026 | Oct 5, 2026 |
| 144 | Notice of proposed sale | Oct 5, 2026 | — |
| 4 | Insider transaction | Sep 30, 2026 | Sep 30, 2026 |
| 4 | Insider transaction | Sep 30, 2026 | Sep 28, 2026 |
| 144 | Notice of proposed sale | Sep 28, 2026 | — |
| 4 | Insider transaction | Sep 24, 2026 | Sep 22, 2026 |
| 144 | Notice of proposed sale | Sep 22, 2026 | — |
| 4 | Insider transaction | Aug 19, 2026 | Aug 18, 2026 |
| 144 | Notice of proposed sale | Aug 18, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 17, 2026 | — |
| 4 | Insider transaction | Aug 17, 2026 | Aug 13, 2026 |
| 13F-NT | Filing | Aug 14, 2026 | Jun 30, 2026 |
| 144 | Notice of proposed sale | Aug 13, 2026 | — |
| 144 | Notice of proposed sale | Aug 12, 2026 | — |
| 144 | Notice of proposed sale | Aug 12, 2026 | — |
| 4 | Insider transaction | Aug 7, 2026 | Aug 5, 2026 |
| 4 | Insider transaction | Aug 7, 2026 | Aug 5, 2026 |
| 4 | Insider transaction | Aug 7, 2026 | Aug 5, 2026 |
| 4 | Insider transaction | Aug 7, 2026 | Aug 5, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jun 30, 2026 |
| 144 | Notice of proposed sale | Jul 1, 2026 | — |
| 144 | Notice of proposed sale | Jul 1, 2026 | — |
| 4 | Insider transaction | Jun 30, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jun 25, 2026 | Jun 24, 2026 |
| 4 | Insider transaction | Jun 25, 2026 | Jun 23, 2026 |
| 144 | Notice of proposed sale | Jun 24, 2026 | — |
| 144 | Notice of proposed sale | Jun 23, 2026 | — |
| 144 | Notice of proposed sale | Jun 23, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jun 16, 2026 | — |
| 4 | Insider transaction | Jun 8, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 5, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | May 28, 2026 | May 26, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
May 28, 2026 | May 22, 2026 |
| 144 | Notice of proposed sale | May 26, 2026 | — |
| 4 | Insider transaction | May 21, 2026 | May 20, 2026 |
| 144 | Notice of proposed sale | May 20, 2026 | — |
| 4 | Insider transaction | May 15, 2026 | May 14, 2026 |
| 4 | Insider transaction | May 15, 2026 | May 14, 2026 |
| 144 | Notice of proposed sale | May 14, 2026 | — |
| 144 | Notice of proposed sale | May 14, 2026 | — |
| 13F-NT | Filing | May 14, 2026 | Mar 31, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 14, 2026 | — |
| 4 | Insider transaction | May 8, 2026 | May 6, 2026 |
| 4 | Insider transaction | May 8, 2026 | May 6, 2026 |
| 4 | Insider transaction | May 8, 2026 | May 6, 2026 |
| 4 | Insider transaction | May 8, 2026 | May 6, 2026 |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 6, 2026 | May 6, 2026 |
| 4 | Insider transaction | Apr 30, 2026 | Apr 28, 2026 |
| 144 | Notice of proposed sale | Apr 28, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 13, 2026 | Apr 13, 2026 |
| ARS | Annual report to shareholders | Apr 10, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 10, 2026 | — |
| DEF 14A | Proxy statement | Apr 10, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Apr 1, 2026 |
| 144 | Notice of proposed sale | Apr 1, 2026 | — |
| 13F-NT | Filing | Apr 1, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Mar 31, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Mar 25, 2026 | Mar 23, 2026 |
| 144 | Notice of proposed sale | Mar 23, 2026 | — |
| 144 | Notice of proposed sale | Mar 19, 2026 | — |
| 144 | Notice of proposed sale | Mar 18, 2026 | — |
| 4 | Insider transaction | Mar 4, 2026 | Mar 2, 2026 |
| 144 | Notice of proposed sale | Mar 4, 2026 | — |
| 144 | Notice of proposed sale | Mar 2, 2026 | — |
| 4 | Insider transaction | Feb 25, 2026 | Feb 23, 2026 |
| 144 | Notice of proposed sale | Feb 23, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Feb 20, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| 4 | Insider transaction | Feb 13, 2026 | Feb 11, 2026 |
| 4 | Insider transaction | Feb 13, 2026 | Feb 11, 2026 |
| 4 | Insider transaction | Feb 13, 2026 | Feb 11, 2026 |
| 4 | Insider transaction | Feb 13, 2026 | Feb 11, 2026 |
| 10-K | Annual report | Feb 11, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 11, 2026 | Feb 11, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 144 | Notice of proposed sale | Feb 3, 2026 | — |
| 144 | Notice of proposed sale | Feb 2, 2026 | — |
| 4 | Insider transaction | Feb 2, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Jan 26, 2026 | Jan 23, 2026 |
| 4 | Insider transaction | Jan 23, 2026 | Jan 20, 2026 |
| 4 | Insider transaction | Jan 20, 2026 | Jan 16, 2026 |
| 144 | Notice of proposed sale | Jan 20, 2026 | — |
| 4 | Insider transaction | Jan 13, 2026 | Jan 9, 2026 |
| 144 | Notice of proposed sale | Jan 7, 2026 | — |
| 3 | Initial insider ownership | Jan 6, 2026 | Jan 1, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 144 | Notice of proposed sale | Jan 2, 2026 | — |
| 4 | Insider transaction | Jan 2, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Dec 29, 2025 | Dec 26, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 22, 2025 | Dec 20, 2025 |
| 4 | Insider transaction | Dec 22, 2025 | Dec 19, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 22, 2025 | Dec 19, 2025 |
| 4 | Insider transaction | Dec 19, 2025 | Dec 17, 2025 |
| 4 | Insider transaction | Dec 17, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 17, 2025 | Dec 15, 2025 |
| 144 | Notice of proposed sale | Dec 16, 2025 | — |
| 144 | Notice of proposed sale | Dec 15, 2025 | — |
| 4 | Insider transaction | Dec 9, 2025 | Dec 5, 2025 |
| 4 | Insider transaction | Dec 5, 2025 | Dec 3, 2025 |
| 4 | Insider transaction | Dec 3, 2025 | Dec 1, 2025 |
| 4 | Insider transaction | Dec 3, 2025 | Dec 1, 2025 |
| 144 | Notice of proposed sale | Dec 1, 2025 | — |
| 144 | Notice of proposed sale | Dec 1, 2025 | — |
| 144 | Notice of proposed sale | Dec 1, 2025 | — |
| 4 | Insider transaction | Nov 26, 2025 | Nov 24, 2025 |
| 144 | Notice of proposed sale | Nov 24, 2025 | — |
| 4 | Insider transaction | Nov 21, 2025 | Nov 19, 2025 |
| 144 | Notice of proposed sale | Nov 19, 2025 | — |
| 4 | Insider transaction | Nov 19, 2025 | Nov 17, 2025 |
| 144 | Notice of proposed sale | Nov 17, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 13, 2025 | — |
| 4 | Insider transaction | Nov 7, 2025 | Nov 5, 2025 |
| 4 | Insider transaction | Nov 7, 2025 | Nov 5, 2025 |
| 4 | Insider transaction | Nov 7, 2025 | Nov 5, 2025 |
| 4 | Insider transaction | Nov 7, 2025 | Nov 5, 2025 |
| 4 | Insider transaction | Nov 7, 2025 | Nov 5, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 5, 2025 | — |
| 10-Q | Quarterly report | Nov 5, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2025 | Nov 5, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 30, 2025 | — |
| 4 | Insider transaction | Sep 30, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 16, 2025 | Sep 16, 2025 |
| 424B2 | Prospectus | Sep 3, 2025 | — |
| FWP | Free writing prospectus | Sep 3, 2025 | — |
| 424B2 | Prospectus | Sep 2, 2025 | — |
| POSASR | Filing | Sep 2, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Aug 13, 2025 | Aug 13, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 13, 2025 | — |
| 4 | Insider transaction | Aug 11, 2025 | Aug 8, 2025 |
| 144 | Notice of proposed sale | Aug 11, 2025 | — |
| 4 | Insider transaction | Aug 8, 2025 | Aug 6, 2025 |
| 4 | Insider transaction | Aug 8, 2025 | Aug 6, 2025 |
| 4 | Insider transaction | Aug 8, 2025 | Aug 6, 2025 |
| 4 | Insider transaction | Aug 8, 2025 | Aug 6, 2025 |
| 4 | Insider transaction | Aug 8, 2025 | Aug 6, 2025 |
| 10-Q | Quarterly report | Aug 6, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2025 | Aug 6, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 5, 2025 | — |
| 4 | Insider transaction | Jul 31, 2025 | Jul 31, 2025 |
| 4 | Insider transaction | Jul 31, 2025 | Jul 31, 2025 |
| 3 | Initial insider ownership | Jul 25, 2025 | Jul 17, 2025 |
| 3 | Initial insider ownership | Jul 25, 2025 | Jul 17, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 17, 2025 | Jul 17, 2025 |
| 4 | Insider transaction | Jun 30, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jun 30, 2025 | Jun 30, 2025 |
| SCHEDULE 13D | Ownership over 5% (active) | May 23, 2025 | — |
| 4 | Insider transaction | May 20, 2025 | May 16, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 16, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 16, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 16, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 16, 2025 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, New debt, Officer or director change, Bylaw or fiscal year change
|
May 19, 2025 | May 16, 2025 |
| S-8 | Employee stock plan registration | May 16, 2025 | — |
| 4 | Insider transaction | May 15, 2025 | May 13, 2025 |
| 4 | Insider transaction | May 14, 2025 | May 13, 2025 |
| 4 | Insider transaction | May 14, 2025 | May 13, 2025 |
| 4 | Insider transaction | May 14, 2025 | May 13, 2025 |
| 4 | Insider transaction | May 14, 2025 | May 13, 2025 |
| 4 | Insider transaction | May 14, 2025 | May 13, 2025 |
| 4 | Insider transaction | May 14, 2025 | May 13, 2025 |
| 4 | Insider transaction | May 14, 2025 | May 13, 2025 |
| 4 | Insider transaction | May 14, 2025 | May 12, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 12, 2025 | May 12, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 12, 2025 | — |
| 4 | Insider transaction | May 9, 2025 | May 8, 2025 |
| 4 | Insider transaction | May 9, 2025 | May 8, 2025 |
| 4 | Insider transaction | May 9, 2025 | May 8, 2025 |
| 4 | Insider transaction | May 9, 2025 | May 8, 2025 |
| 4 | Insider transaction | May 9, 2025 | May 8, 2025 |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 2, 2025 | — |
| 4 | Insider transaction | Apr 21, 2025 | Apr 21, 2025 |
| 3/A | Form 3/a | Apr 21, 2025 | Apr 7, 2025 |
| 3 | Initial insider ownership | Apr 21, 2025 | Apr 7, 2025 |
| DEFA14A | Additional proxy material | Apr 11, 2025 | — |
| 8-K |
Current report
Material agreement
|
Apr 11, 2025 | Apr 11, 2025 |
| ARS | Annual report to shareholders | Apr 11, 2025 | Dec 31, 2024 |
| DEFM14A | Filing | Apr 11, 2025 | — |
| DEFA14A | Additional proxy material | Apr 10, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Apr 10, 2025 | Apr 7, 2025 |
| UPLOAD | Letter from the SEC | Apr 9, 2025 | — |
| CORRESP | Letter to the SEC | Apr 4, 2025 | — |
| 4 | Insider transaction | Apr 1, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 1, 2025 | Mar 31, 2025 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RPRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- United Kingdom
- Headquarters
- New York, NY
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1802768
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.